Proteomics Market Projected to have a Stable Growth for the Upcoming Years

Proteomes are an entire set of proteins which is expressed in genomes, and proteomics refers to the large-scale study of these proteomes, that include study of the functions and structure of proteins that can be used in diagnosis and treatment of various diseases, and in the process of drug discovery. Proteomics is used to analyze the interaction of proteins with each other, action of proteins in metabolic pathways, rate of the production of proteins, and the modification process of the proteins. Additionally, it is extensively applied in personalized medicine development, and marker identification for disease diagnosis. Global proteomics market is expected to grow significantly in the forecasted period due to the rising demand for personalized medicine and increasing investment in research and development activities, globally.

Download report sample at: http://bit.ly/2BBzffq

Based on the instrumentation technology, the global proteomics market is segmented into protein microarrays, spectroscopy, x-ray crystallography, chromatography, electrophoresis, surface plasmon resonance (SPR) systems, and protein fractionation systems. Protein microarray held the largest segment of the global market in 2016, mainly due to its ability to produce large number of results from a small sample. Moreover, it provides label-free detection, full imprint of proteins, and direct and absolute quantification.

On the basis of reagents, the global proteomics market is segmented into microarray reagents, protein fractionation reagents, spectroscopy reagents, x-ray crystallography reagents, chromatography reagents, electrophoresis reagents, and immunoassay reagents. Protein fractionation reagents are expected to have a significant growth during the period 2017 - 2023, mainly due to its increased application in simplifying complex proteins and making the research processes easier.

Based on software and services, analytical laboratory services held largest share of the global proteomics market in 2016, mainly due to increasing research and development investments by the key players in the market and government. The global proteomics market finds application in drug discovery, clinical diagnosis, and other applications. Based on application, clinical diagnostics held the largest share of the global proteomics market in 2016, driven by increasing understanding of proteins and its application in the drug discovery.

Browse full report at: http://bit.ly/2SeTxR8

Geographically, North America was the largest market for Proteomics in 2016, followed by Europe. The North American proteomics market is primarily driven by easily available funds from various institutions for proteomic research using innovative technologies.

Agilent Technologies Inc., Bruker Corporation, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Waters Corporation, Danaher Corporation, Luminex Corporation, and PerkinElmer Inc. are some of the key players in the global proteomics market.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarenews.home.blog/

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.